BeStock  

Teva Pharmaceutical Industries TEVA

US equityMarket cap rank #452Infectious DiseaseCannabis & Hemp
$39.23 +$0.69 (+1.79%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $39.23 0.00%
Open$38.46
Prev close$38.54
Day range$38.30 – $39.91
Volume6.81M
Market cap$45.77B
P/E (TTM)91.2
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$4.39B-1.9% YoY
Operating profit$1.14B+5.7% YoY
Net profit$234.00M-46.1% YoY
Diluted EPS$0.20-45.9% YoY
Free cash flow$75.00M-66.1% YoY
Operating cash flow$241.00M

Revenue, last 8 quarters

$4.2BDec '24$3.9BMar '25$4.2BJun '25$4.5BSep '25$4.7BDec '25$4.0BMar '26$4.1BJun '26$4.4BSep '26

Net profit, last 8 quarters

$-275.0MDec '24$220.0MMar '25$283.0MJun '25$434.0MSep '25$481.0MDec '25$369.0MMar '26$-575.0MJun '26$234.0MSep '26

Diluted EPS by quarter

-0.19Dec '240.18Mar '250.24Jun '250.37Sep '250.41Dec '250.31Mar '26-0.49Jun '260.20Sep '26

Free cash flow by quarter

$446.0MDec '24$-232.0MMar '25$131.0MJun '25$221.0MSep '25$1.1BDec '25$-208.0MMar '26$307.0MJun '26$75.0MSep '26

Annual revenue

$16.7BFY20$15.9BFY21$14.9BFY22$15.8BFY23$16.5BFY24$17.3BFY25

Profitability & balance sheet

Gross margin53.5%
Operating margin19.2%
Net margin2.9%
Return on equity6.6%
Return on assets1.3%
Return on invested capital4.7%
Current ratio0.95
Liabilities / assets80.1%
Cash & investments$4.09B
Total debt$16.98B
Net cash (debt)-$12.90B
Free cash flow / sales3.1%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Generic products (including biosimilars)$2.16B 57.1%
  • AUSTEDO$751.00M 19.9%
  • Other$330.00M 8.7%
  • AJOVY$270.00M 7.1%
  • COPAXONE$104.00M 2.7%
  • UZEDY$85.00M 2.2%
  • Respiratory products$54.00M 1.4%
  • BENDEKA and TREANDA$30.00M 0.8%

SEC annual financial snapshot

Standard US-GAAP figures from 10-K filings in USD. Figures may reflect restatements. Checked 2026-11-21 16:51 UTC.

MetricUSDBasisPeriod endFiled / SEC source
Revenue$17.26BAnnual2025-12-312026-02-03
Net income$1.41BAnnual2025-12-312026-02-03
Operating cash flow$1.65BAnnual2025-12-312026-02-03
Total assets$40.75BPeriod end2025-12-312026-02-03
Total liabilities$32.83BPeriod end2025-12-312026-02-03
Stockholders’ equity$7.91BPeriod end2025-12-312026-02-03
Cash and cash equivalents$3.56BPeriod end2025-12-312026-02-03

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $4.40B $4.14B $3.98B $17.26B $4.71B
Total Operating Revenue $4.39B $4.14B $3.98B $17.26B $4.71B
Cost of Revenue $1.96B $1.99B $2.01B $8.32B $2.06B
Gross Profit $2.44B $2.15B $1.97B $8.94B $2.66B
Operating Expense $1.30B $2.00B $1.21B $4.99B $1.39B
Selling and Admin Expenses $1.01B $1.03B $1.00B $3.97B $1.12B
-Selling & Marketing Expense $709.00M $717.00M $696.00M $2.69B $753.00M
-General & Admin Expense $298.00M $317.00M $304.00M $1.29B $367.00M
Research & Development $297.00M $970.00M $222.00M $1.01B $267.00M
Operating Profit $1.14B $149.00M $759.00M $3.95B $1.27B
Net Non-Operating Interest Income (Expense) -$190.00M -$224.00M -$216.00M -$985.00M -$271.00M
Non-Operating Interest Expense $174.00M $195.00M $201.00M $916.00M $292.00M
Total Other Finance Costs $16.00M $29.00M $15.00M $69.00M -$21.00M
Other Income (Expense) -$646.00M -$379.00M -$107.00M -$1.74B -$916.00M
Special Income (Charges) -$714.00M -$398.00M -$111.00M -$1.79B -$985.00M
-Less:Restructuring and Mergern & Acquisition $60.00M $55.00M $30.00M $279.00M $37.00M
-Less:Impairment of Capital Assets $228.00M $113.00M $9.00M $1.03B $773.00M
-Less:Other Special Charges $426.00M $230.00M $72.00M $467.00M $155.00M
Other Non-Operating Income (Expenses) $68.00M $19.00M $4.00M $1.00M $18.00M
Pretax Profit $300.00M -$455.00M $437.00M $1.22B $80.00M
Tax $66.00M $121.00M $67.00M -$180.00M -$390.00M
Net Profit $234.00M -$575.00M $369.00M $1.42B $481.00M
Profit from Continuing Operations $234.00M -$576.00M $369.00M $1.42B $481.00M
Minority Interests $1.00M – – $7.00M $0.00
Net Income to Parent Company $233.00M -$576.00M $369.00M $1.41B $480.00M
Net Income to Common Stockholders $233.00M -$576.00M $369.00M $1.41B $480.00M
Basic EPS $0.20 -$0.49 $0.32 $1.23 $0.42
Diluted EPS $0.20 -$0.49 $0.31 $1.21 $0.41
Dividend Per Share $0.00 $0.00 $0.00 $0.00 $0.00
Other Operating Expenses – – -$9.00M – –
– – $1.00M -$15.00M -$11.00M
Gain on Sale of Security – – – $51.00M –
-Gain on Sale Of Business – – – -$22.00M –
-Gain on Sale of Property/Plant/Equipment – – – $2.00M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $40.04B $39.86B $40.04B $40.75B $40.75B
Total Current Assets $14.60B $13.76B $13.71B $13.95B $13.95B
Cash and Cash Equivalents & Short-Term Investments $4.09B $3.66B $3.74B $3.56B $3.56B
-Cash and Cash Equivalents $4.09B $3.66B $3.74B $3.56B $3.56B
Receivables $3.84B $3.49B $3.39B $3.71B $3.71B
-Accounts Receivable $3.84B $3.49B $3.39B $3.71B $3.71B
Prepaid Assets $1.01B $1.03B $1.07B $1.12B $1.12B
Inventory $3.17B $3.22B $3.18B $3.18B $3.18B
Other Current Assets $657.00M $563.00M $536.00M $538.00M $538.00M
Total Non-Current Assets $25.44B $26.10B $26.33B $26.80B $26.80B
Net PPE $4.07B $4.26B $4.33B $4.43B $4.43B
-Gross PPE $4.07B $4.26B $4.33B $9.15B $9.15B
Goodwill and Other Intangible Assets $19.05B $19.29B $19.43B $19.78B $19.78B
-Goodwill $15.74B $15.84B $15.82B $16.00B $16.00B
-Other Intangible Assets $3.30B $3.45B $3.61B $3.78B $3.78B
Non-Current Deferred Assets $2.06B $2.16B $2.19B $2.19B $2.19B
Other Non-Current Assets $269.00M $387.00M $377.00M $405.00M $405.00M
Total Liabilities $32.06B $32.10B $31.81B $32.83B $32.83B
Total Current Liabilities $15.43B $15.65B $13.53B $13.46B $13.46B
Payables $2.55B $2.72B $2.60B $2.53B $2.53B
-Accounts Payable $2.55B $2.72B $2.60B $2.53B $2.53B
Current Accrued Expenses $2.96B $2.74B $2.62B $2.69B $2.69B
Short-Term Debt and Capital Lease Obligation $4.04B $4.50B $2.61B $1.82B $1.82B
-Current Debt $4.04B $4.50B $2.61B $1.82B $1.82B
Current Provisions $3.96B $3.90B $3.71B $4.14B $4.14B
Other Current Liabilities $1.33B $1.30B $1.45B $1.54B $1.54B
Total Non-Current Liabilities $16.63B $16.45B $18.28B $19.38B $19.38B
Long Term Debt and Capital Lease Obligation $12.95B $12.37B $14.30B $15.27B $15.27B
-Long Term Debt $12.68B $12.09B $14.02B $14.99B $14.99B
-Long Term Capital Lease Obligation $266.00M $282.00M $280.00M $288.00M $288.00M
Non-Current Deferred Liabilities $263.00M $289.00M $273.00M $296.00M $296.00M
Other Non-Current Liabilities $3.42B $3.79B $3.71B $3.81B $3.81B
Total Equity $7.98B $7.76B $8.23B $7.91B $7.91B
Stockholders' Equity $7.98B $7.75B $8.23B $7.91B $7.91B
Capital Stock $59.00M $59.00M $59.00M $58.00M $58.00M
-Common Stock $59.00M $59.00M $59.00M $58.00M $58.00M
Additional Paid-In Capital $28.31B $28.26B $28.20B $28.13B $28.13B
Retained Earnings -$13.74B -$13.97B -$13.39B -$13.76B -$13.76B
Less: Treasury Stock -$4.10B -$4.13B -$4.13B -$4.13B -$4.13B
Gains/Losses Not Affecting Retained Earnings -$2.56B -$2.47B -$2.51B -$2.39B -$2.39B
Minority Interests $5.00M $4.00M $4.00M $4.00M $4.00M
-Accumulated Depreciation – – – -$4.73B -$4.73B

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $241.00M $411.00M -$40.00M $1.65B $1.16B
Net cash flow from continuing operations $241.00M $411.00M -$40.00M $1.65B $1.16B
Net Income from Continuing Operations $234.00M -$575.00M $369.00M $1.42B $481.00M
Gain/Loss from Continuing Operations $155.00M -$12.00M -$8.00M – –
Depreciation & Depletion & Amortization $245.00M $241.00M $239.00M $1.00B $260.00M
Deferred Tax $53.00M $25.00M -$22.00M -$671.00M -$595.00M
Other Non-Cash Items -$30.00M $743.00M -$54.00M $81.00M -$93.00M
Change in Working Capital -$682.00M -$164.00M -$617.00M -$1.37B $281.00M
Net cash flow from investing $210.00M -$491.00M $229.00M $737.00M $165.00M
Net Cash Flow from Continuing Investing Activities $210.00M -$490.00M $229.00M $737.00M $165.00M
Net PPE Purchase and Sale -$120.00M -$104.00M -$168.00M -$501.00M -$142.00M
Net Intangibles Purchase and Sale -$46.00M – – – –
Net Business Purchase and Sale $47.00M -$692.00M $42.00M $34.00M $0.00
Net Other Investing Changes $2.00M -$5.00M $1.00M $5.00M -$1.00M
Financing Cash Flow $6.00M -$1.00M $13.00M -$2.15B $40.00M
Net Cash Flow from Continuing Financing Activities $5.00M -$1.00M $13.00M -$2.15B $40.00M
Net Issuance Payments Of Debt -$38.00M $0.00 -$23.00M -$1.81B $0.00
Net Other Financing Charges $44.00M -$1.00M $36.00M -$337.00M $40.00M
Ending Cash Balance $4.09B $3.66B $3.74B $3.56B $3.56B
Net Change in Cash $457.00M -$81.00M $202.00M $235.00M $1.36B
Beginning Cash Balance $3.66B $3.74B $3.56B $3.30B $2.20B
Effect of Exchange Rate Changes -$27.00M -$5.00M -$17.00M $21.00M -$10.00M
Free Cash Flow $75.00M $307.00M -$208.00M $1.15B $1.06B
Net Investment Purchase and Sale – -$1.00M $0.00 -$15.00M $25.00M
-Change in Receivables – – – -$173.00M –
-Change in Inventory – – – $152.00M –
-Change in Payables and Accrued Expense – – – -$15.00M –
-Change in Other Current Assets – – – -$1.33B –

Discussion

No comments yet — be the first to weigh in on TEVA.

Sign in to join the discussion.

Scroll to Top